UBI Pharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chei-Hsiang Chen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.3yrs |
| CEO ownership | n/a |
| Management average tenure | 6.2yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Chei-Hsiang Chen
4.3yrs
Tenure
Dr. Chei-Hsiang Chen, Ph.D. has been President of UBI Pharma Inc. since January 2020 and has been its Chairperson since December 2019. He serves as General Manager at UBI Pharma Inc. Dr. Chen serves as the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairperson | 4.3yrs | no data | no data | |
| Manager of the Finance Department | 8.1yrs | no data | no data | |
| Chief Operating Officer | 10.3yrs | no data | no data | |
| Manager of Accounting Department | no data | no data | no data | |
| Executive VP | 4.3yrs | no data | no data | |
| COO of Pharmaceutical Business Center & Director | no data | no data | no data |
6.2yrs
Average Tenure
Experienced Management: 6562's management team is seasoned and experienced (6.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairperson | 4.4yrs | no data | no data | |
| Executive VP | 4.3yrs | no data | no data | |
| COO of Pharmaceutical Business Center & Director | no data | no data | no data | |
| Independent Director | 4.3yrs | no data | no data | |
| Director | no data | no data | no data |
4.3yrs
Average Tenure
Experienced Board: 6562's board of directors are considered experienced (4.3 years average tenure).